Related Experiment Video
Updated: Feb 10, 2026

06:40
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
1.8K
Summary
Cancer treatments are more effective with fewer side effects, but high drug prices may make them unaffordable for patients. This issue impacts payers, providers, policymakers, and drugmakers.
Area of Science:
- Oncology
- Pharmacoeconomics
- Healthcare Policy
Background:
- Recent advancements in cancer treatment have led to more effective therapies with improved side effect profiles.
- Despite scientific progress, the high cost of these innovative cancer drugs presents a significant challenge to accessibility.
Purpose of the Study:
- To examine the growing issue of high cancer drug prices and their impact on patient affordability.
- To explore the perspectives of various stakeholders, including payers, providers, policymakers, and pharmaceutical manufacturers, on this challenge.
Main Methods:
- Qualitative analysis of current trends in cancer drug pricing.
- Review of stakeholder discussions and policy debates surrounding treatment affordability.
Main Results:
- Cancer treatments are medically advanced, offering significant benefits over older therapies.
- A substantial number of patients are unable to afford life-saving treatments due to escalating costs.
Conclusions:
- The effectiveness of modern cancer therapies is contrasted by their increasing unaffordability.
- Urgent attention is required from all stakeholders to address the pricing crisis and ensure patient access to essential cancer treatments.
Related Concept Videos
Cancer
54.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K
Pharmacokinetics: Drug–Drug Interactions
462
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
462
What is Cancer?
14.5K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K
Bioequivalence of Drugs: Drugs with Multiple Indications
163
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
163
FDA Approved Drugs: Changes to Approved Drugs
273
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
273
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
262
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
262

